Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques

Free Radical Biology and Medicine

Volumn 42, Issue 4, 2007, Pages 492-498

  Lapenna, Domenico ^a   Pierdomenico, Sante D ^a   Ciofani, Giuliano ^a   Ucchino, Sante ^a   Neri, Matteo ^a   Giamberardino, Maria Adele ^a   Cuccurullo, Franco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Atherosclerosis; Ferritin; Iron; Oxidant damage

Indexed keywords

FERRITIN; IRON;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CATALYSIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ENDARTERECTOMY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; MOLECULAR WEIGHT; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; ATHEROSCLEROSIS; BODY BURDEN; FEMALE; HUMANS; IRON; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OXIDANTS;

EID: 33846549431     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.11.014     Document Type: Article

References (48)

1. Chisolm G.M., and Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28 (2000) 1815-1826
2. Young I.S., and McEneny J. Lipoprotein oxidation and atherosclerosis. Biochem. Soc. Trans. 29 (2001) 358-362
3. Halliwell B., and Gutteridge J.M.C. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186 (1990) 1-85
4. Walters G.O., Miller F.M., and Worwood M. Serum ferritin concentration and iron stores in normal subjects. J. Clin. Pathol. 26 (1973) 770-772
5. Jacobs A. Serum ferritin and iron stores. Fed. Proc. 36 (1977) 2024-2027
6. Ledue T.B., Craig W.Y., Ritchie R.F., and Haddow J.E. The influence of blood donation and iron supplementation on indicators of iron status. Clin. Chem. 40 (1994) 1345-1346
7. You S.-A., and Wang Q. Ferritin in atherosclerosis. Clin. Chim. Acta 357 (2005) 1-16
8. Reif D.W. Ferritin as a source of iron for oxidative damage. Free Radic. Biol. Med. 12 (1992) 417-427
9. Abdalla D.S.P., Campa A., and Monteiro H.P. Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Atherosclerosis 97 (1992) 149-159
10. Salonen J.T., Nyyssönen K., Korpela H., Tuomileto J., Seppänen R., and Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86 (1992) 803-811
11. Tuomainen T.-P., Punnonen K., Nyyssönen K., and Salonen J. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97 (1998) 1461-1466
12. Meyers D.G. The iron hypothesis: does iron play a role in atheroslerosis?. Transfusion 40 (2000) 1023-1029
13. Kiechl S., Aichner F., Gerstenbrand F., Egger G., Mair A., Rungger G., Spögler F., Jarosch E., Oberhollenzer F., and Willeit J. Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study. Arterioscler. Thromb. 14 (1994) 1625-1630
14. Kiechl S., Willeit J., Egger G., Poewe W., Oberhollenzer F., and for the Bruneck Study Group. Body iron stores and the risk of carotid atherosclerosis. Prospective results from the Bruneck study. Circulation 96 (1997) 3300-3307
15. Wolff B., Völzke H., Lüdermann J., Robinson D., Vogelgesang D., Staudt A., Kessler C., Dahm J.B., John U., and Felix S.B. Association between high serum ferritin levels and carotid atherosclerosis in the Study of Health in Pomerania (SHIP). Stroke 35 (2004) 453-457
16. Baer D.M., Tekawa I.S., and Hurley L.B. Iron stores are not associated with acute myocardial infarction. Circulation 89 (1994) 2915-2918
17. Sempos C.T., Looker A.C., Gillum R.F., and Makuc D.M. Body iron stores and the risk of coronary heart disease. N. Engl. J. Med. 330 (1994) 1119-1124
18. Rauramaa R., Väisänen S., Mercuri M., Rankinen T., Penttilä I., and Bond M.G. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged Eastern Finnish men. Eur. Heart J. 15 (1994) 1020-1027
19. Moore M., Folsom A.R., Bames R.W., and Eckfeld J.H. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Epidemiol. 141 (1995) 719-723
20. Fuhrman B., Oiknine J., and Aviram M. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Atherosclerosis 111 (1994) 65-78
21. Dillard C.J., and Tappel A.L. Fluorescent products of lipid peroxidation of mitochondria and microsomes. Lipids 6 (1971) 715-721
22. Dillard C.J., and Tappel A.L. Fluorescent damage products of lipid peroxidation. Methods Enzymol. 105 (1984) 337-348
23. Fukuda F., Kitada M., Horie T., and Awazu S. Evaluation of adriamycin-induced lipid peroxidation. Biochem. Pharmacol. 44 (1992) 755-760
24. Gay C., Collins J., and Gebicki J.M. Hydroperoxide assay with the ferric-xylenol orange complex. Anal. Biochem. 273 (1999) 149-155
25. Nourooz-Zadeh J., Tajaddini-Sarmadi J., and Wolff S.P. Measurement of plasma hydroperoxide concentration by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal. Biochem. 220 (1994) 403-409
26. Lapenna D., Ciofani G., Pierdomenico S.D., Di Gioacchino M., Neri M., Sabbioni E., and Cuccurullo F. Transmural distribution of iron in the hypoxic and reoxygenated rabbit left ventricular myocardium. BioMetals 17 (2004) 359-363
27. Altman D.G. Practical statistics for medical research (1991), Chapman and Hall, London
28. Stadler N., Lindner R.A., and Davies M.J. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1-7
29. McNamara L., MacPhail A.P., Mandishona E., Bloom P., Paterson A.C., Rouault T.A., and Gordeuk V.R. Non-transferrin-bound iron and hepatic dysfunction in African dietary overload. J. Gastroenterol. Hepatol. 14 (1999) 126-132
30. Smith C., Mitchinson M.J., Aruoma O.I., and Halliwell B. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286 (1992) 901-905
31. Lee F.-Y., Lee T.-S., Pan C.-C., Huang A.-L., and Chau L.-Y. Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis 138 (1998) 281-288
32. Leake D.S. Does an acidic pH explain why low density lipoprotein is oxidized in atherosclerotic lesions?. Atherosclerosis 129 (1997) 149-157
33. Schafer F.Q., and Buettner G.R. Acidic pH amplifies iron-mediated lipid peroxidation in cells. Free Radic. Biol. Med. 28 (2000) 1175-1181
34. Pang J.-H.S., Jiang M.-J., Chen Y.-L., Wang F.-W., Wang D.L., and Chu S.-H. Increased ferritin gene expression in atherosclerotic lesions. J. Clin. Invest. 97 (1996) 2204-2212
35. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., and Heinecke J.W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272 (1997) 3520-3526
36. Suarna C., Dean R.T., May J., and Stocker R. Human atherosclerotic plaques contain both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1616-1624
37. Gutteridge J.M.C. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett. 201 (1986) 291-295
38. Ryter S.W., and Tyrrell R.M. The heme synthesis and degradation pathway: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic. Biol. Med. 28 (2000) 289-309
39. Wang L.J., Lee T.S., Lee F.Y., Pai R.C., and Chau L.Y. Expression of heme oxygenase-1 in atherosclerotic lesions. Am. J. Pathol. 152 (1998) 711-720
40. Greenspan P., Yu H., Gutman R.L., Mao F., Ryu B.-H., and Lou P. Iron-ascorbate-phospholipid mediated modification of low density lipoprotein. Biochim. Biophys. Acta 1301 (1996) 242-248
41. Mackness M.I., and Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 115 (1995) 243-253
42. Ascherio A., and Willett W.C. Are body iron stores related to the risk of coronary heart disease?. N. Engl. J. Med. 330 (1994) 1152-1154
43. Sullivan J.L. The iron paradigm of ischemic heart disease. Am. Heart J. 117 (1989) 1177-1188
44. Sullivan J.L. Is stored iron safe?. J. Lab. Clin. Med. 144 (2004) 280-284
45. Sullivan J.L. Blood donation, iron depletion, and vascular integrity. Atherosclerosis 175 (2004) 381
46. Zheng H., Cable R., Spencer B., Votto N., and Katz S.D. Iron stores and vascular function in voluntary blood donors. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1577-1583
47. Giles W.H., Anda R.F., Williamson D.F., Yip R., and Marks J. Iron and ischemic heart disease. Circulation 87 (1993) 2065-2066
48. Sullivan J.L. Iron, asymptomatic carotid atherosclerosis, and myocardial infarction. Am. J. Epidemiol. 141 (1995) 719-723